If I've interpreted the first question right, I think you'll find that it is in fact P&G who is required to provide OBJ minimum funding including R&D expenditure to maintain the commercial exclusivity granted to P&G under the PDA.
In regards to your 2nd question I share a similar view to you. To my understanding OBJ receives a licensing fee for each new 'territory', milestone payments on predetermined targets, and of course royalties as a percentage on wholesale units sold.
I wouldn't expect to see revenue earnings for OBJ above $2m in this financial year, however multiple product global launch campaigns executed by P&G will be far more difficult to miss, and I think the market will be awoken by this event in the not too distant future.
(20min delay)